InvestorsHub Logo
Followers 4
Posts 363
Boards Moderated 0
Alias Born 12/14/2016

Re: Rapture2020 post# 27637

Friday, 12/15/2017 10:37:38 PM

Friday, December 15, 2017 10:37:38 PM

Post# of 50154
@Rap - Initially, I thought the same thing - that they brought him on board because of his expertise in commercialization and navigating the FDA approval process. And, while I'm sure that's true, I do find one thing fairly puzzling. I was reading a bit about Athenex, and it would seem that they could be viewed as a competitor of Delcath. So it begs the question: How does Dr. Pedder not have a conflict of interest serving on the board of a company that is a potential competitor? Unless, there is something else in play ....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News